AXE Price sensitive 27 Aug 2026, 9:30 AM

Appendix 4E and 2026 Annual Report

Archer Materials Ltd

Archer Materials Ltd 2026 Annual Report

Key points

  • Net loss for the year was $6,361,253, an improvement from $6,972,006 in 2025
  • Progress made in quantum and Biochip technology programs
  • Signed a three-year Quantum Compute Agreement with IonQ

Full summary

Archer Materials Ltd reported a net loss of $6,361,253 for the financial year ended 30 June 2026, an improvement from the $6,972,006 loss in the previous year. The company's financial performance was influenced by share-based payments, research and development expenses, and unrealized losses from investments. Despite the loss, Archer made substantial progress in its quantum and Biochip technology programs. The 12CQ program advanced with the development of two readout methods, while the Biochip program moved from proof-of-concept to product development. Archer also entered into a three-year Quantum Compute Agreement with IonQ, providing access to commercial quantum computing systems and technical support. The agreement aims to build an Australian quantum business around cloud access, software applications, and customer engagement.

Outlook

Archer plans to focus on demonstrating a functional 12CQ qubit, progressing the Biochip beta prototype, and building an Australian quantum business around cloud access and software applications.

Sign in for more about this company, including guidance changes and other insights.
Sign in